Former Education Secretary DeVos’ Family Invested in Theranos

Testimony during the Elizabeth Holmes fraud trial revealed the Betsy DeVos’ family doled out $100 million to the now-defunct company.

Omar Ford

November 1, 2021

1 Min Read
IMG_Nov12021at35227PM.jpg
Arek Socha from Pixabay.com

As the Elizabeth Holmes fraud trial presses on, more information is coming out about her investors. The latest bombshell is that Holmes was able to help fund the now-defunct Theranos with the help of the family of former Education Secretary Betsy DeVos.  

The DeVos family doled out $100 million into Theranos after a visit to its Palo Alto, CA headquarters, according to a report from CNN. During the trial, Lisa Peterson, a managing director at RDV, the investment advisory that manages DeVos fortune, testified about the investment, which occurred in 2014, according to the CNN report.

Peterson noted in her testimony that Holmes was handpicking wealthy families to invest in the round, which included the Walton Family, heirs to the Wal-Mart fortune, CNN reported.

The investment from the DeVos family is one of the six wire fraud counts included in the 12 criminal charges Holmes is facing.

The fraud trial is entering into its ninth week and has seen a number of shocking revelations and events including one juror being dismissed because she was playing sudoku during court proceedings.

And late last month, Shane Weber, a former Pfizer scientist testified despite the company rejecting Theranos’s Edison because it did not work, Holmes used the drug makers logo to claim that Pfizer validated the diagnostic, according to a report from CNBC.

Theranos was founded in 2003 and was developing Edison, a diagnostic that had the promise of identifying hundreds of conditions or diseases from a single blood draw. However, the company overstated the effectiveness of Edison – a test that simply did not work.

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like